NICE approves rheumatoid arthritis drug golimumab

NICE has recommended the drug golimumab, in combination with methotrexate, for adults with rheumatoid arthritis whose condition has not responded enough to other disease-modifying anti-rheumatic drugs. A quick guide can be found here and the longer version here.